Founded in 2010, Comprehend Clinical is releasing version 1.0 of its first product Comprehend Clinical. The product is a new enterprise reporting and visualization software package specifically for clinical trials that runs against multiple databases in real time, while leaving the data in place.
Comprehend Clinical is a next-generation ad-hoc reporting tool that runs in any standard web browser and works with any CDMS, CTMS, EDC, Safety, Lab, IVRS, financial, or other systems. Created by engineers with a background in developing similiar products such as Integrated Review and J-Review, Comprehend Clinical is an off-the-shelf solution.
To learn more or setup a demo, visit www.comprehendclinical.com.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
FDA Fast Tracks Johnson & Johnson’s Nipocalimab for Fetal Neonatal Alloimmune Thrombocytopenia
March 27th 2024Johnson & Johnson is moving forward with a pair of Phase III trials of nipocalimab to reduce the risk of fetal neonatal alloimmune thrombocytopenia in alloimmunized pregnant patients.